SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023667
Filing Date
2016-08-09
Accepted
2016-08-09 16:08:52
Documents
54
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 TBRA-Q2-20160630 tbra-10q_20160630.htm 10-Q 1398644
2 EX-31.1 tbra-ex311_7.htm EX-31.1 16971
3 EX-31.2 tbra-ex312_8.htm EX-31.2 18275
4 EX-32.1 tbra-ex321_9.htm EX-32.1 8582
5 EX-32.2 tbra-ex322_11.htm EX-32.2 9084
  Complete submission text file 0001564590-16-023667.txt   4432702

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tbra-20160630.xml EX-101.INS 861968
7 XBRL TAXONOMY EXTENSION SCHEMA tbra-20160630.xsd EX-101.SCH 37938
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbra-20160630_cal.xml EX-101.CAL 35638
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbra-20160630_def.xml EX-101.DEF 100062
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbra-20160630_lab.xml EX-101.LAB 261155
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbra-20160630_pre.xml EX-101.PRE 187163
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35953 | Film No.: 161817963
SIC: 2834 Pharmaceutical Preparations